🇺🇸 FDA
Patent

US 10961535

Compositions and agents against hepatitis B virus and uses thereof

granted A61PA61P1/16A61P31/20

Quick answer

US patent 10961535 (Compositions and agents against hepatitis B virus and uses thereof) held by ARCTURUS THERAPEUTICS, INC. expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/16, A61P31/20